An experienced trialist, Usha leads one of the largest randomised controlled trials to date – the UK Collaborative Trial of Ovarian Cancer Screening which provides the evidence base for all current ovarian cancer screening guidelines. Her research includes large cohort studies assessing screening in high risk women (UK Familial Ovarian Cancer Screening Study), exploring genetic and epidemiological risk factors (UK Ovarian Cancer Population Study), symptoms and intervals to diagnosis of cancer (International Cancer Benchmarking Partnership Module 4) and surgical morbidity (UK Gynaecological Oncology Surgical Outcomes and Complications Study). The trial biobanks with over half a million well-annotated samples and long-term follow-up, support numerous research collaborations and has resulted in a UCL spin-out company.
A major focus recently has been building clinical trials capacity and capability in India. As Adjunct Professor at the Department of Biotechnology, Translational Health Science and Technology Institute (THSTI) and Strategy Lead at the Clinical Development Services Agency, India, she is working with a number of Indian institutions to improve the academic clinical trials ecosystem.
She is an honorary consultant gynaecologist at UCLH NHS Foundation Trust, London, UK.
Well done!
